Etomidate Market Size, Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, France, UK, Italy, Russia, China, Japan, India, Thailand, Indonesia, Malaysia, Australia, Brazil, Mexico, Saudi Arabia, UAE, South Africa), Application Development Potential, Price Trends, Competitive Market Share & Forecast, 2019 - 2025
Report ID: GMI2039
Etomidate Market size will witness noticeable gains owing to extensive use of component in medical industry. The component is a clear colorless solution, free from vision particles that is used for inducing general anesthesia by intravenous injection. It is used for short procedures that includes cardio version, tracheal intubation and dislocated joints.
Growing pharmaceutical industry is expected to drive etomidate market as it is most frequently used as sedative hypnotic agent. It is used for conscious sedation and as a part of a rapid sequence induction to induce anesthesia. It’s easy dosing, limited suppression of ventilation makes it an important medicine in pharmaceutical industry. It is very beneficial for people with unstable hemodynamic and traumatic brain injury as it is the only agent that can reduce intracranial pressure and maintain normal arterial pressure.
Wide usage of the product in speech and memory test has boosted etomidate market. It is used to regulate speech lateralization that is prior to performing lobectomies to remove epileptogenic centers in brain. It is widely used in various medical institutes for memory test and speech. Increasing number of people suffering from speech and memory problem has raised demand of product worldwide.
Product is the only adrenal steroid genesis inhibitor available for parenteral administration. It is extremely useful in situation that needs rapid control on hypercortisolism or in which oral administration is not feasible. High consumption of steroids during injury and health diseases has bolster component demand and simultaneously raised etomidate market in forecast time.
Component plays vital role in increasing metabolism rate in human body. After operating the specified body part, component helps in fast recovery by increasing metabolism rate. Product is also used on animals for conducting various experiments. It is most favorable therapeutic index for single bolus administration. It has unique toxicity that may increase survival of critically ill patients. Its growing usage in clinical literature has positively impacted etomidate market in the forecast period.
Challenges faced by etomidate market are its side effects on human body that include drowsiness, uncontrollable muscle movement, pain in veins, coughing, nausea and vomiting. Long term effects include severe allergies, tightness in chest, difficulty in breathing, swelling of mouth, tongue, lip and face. Growing consumer awareness towards ill effects of the product may its growth in forecast time. Etomidate market is segmented based on application into medical and pharmaceutical industry. Based on product into Lipuro.
Asia Pacific, led by India will witness substantial growth owing to increasing health problems in the region. It is used in various surgeries as anesthesia to help patients bear the pain and for speedy recovery. Increasing population is main factor for surge in diverse health issues. Hectic life style and degrading habits are some factors leading to growing rate of diseases in India. With rising health uncertainties etomidate market is projected to grow.
The U.S. is world’s most important pharmaceutical industry. It stands over 45% of the global pharmaceutical industry. It hosts many top companies which are contributing in the medicine industry on a global basis. Component is extensively used in medical industry for various purposes. With the rise in pharmaceutical industry etomidate market will surge simultaneously in the forecast time.
Component was first developed in Europe in 1972 for medical purposes. Being the oldest market in introducing product, country has strong position in its manufacturing. The component rapidly gained popularity because of its pattern of hemodynamic effect. It is used before operating patients to prevent them from unbearable pain and suffering. With increasing usage of product in medical industry etomidate market is simultaneously surging.
Prominent players in etomidate market include B Braun, Merck, Emcure, Zydus, Mylan, Chengdu Suncadia, Zhejiang Jiuxu, Par Sterile and Luitpold. In 2016, B Braun expanded their manufacturing capacity in Switzerland. Expansion will help the company to maintain continuous growth of their product offering. The facility is one of group’s most modern plant. Company is expecting production number to double by 2020. Advantage of facility is that it employs highly qualified workforce as assembly and packaging are mainly automated there. Expansion will set new standards for the company and will surge its present in the industry.
What Information does this report contain?
Customize this Report
Our Market Research Reports Include:
- Market snapshot
- Market Segmentation
- Value Chain Analysis
- Growth Dynamics
- Potential Market Opportunities
- Regulatory Overview
- Technology Evolution
- Innovation & Sustainability